Cargando…

Expanded Utilization of Intralesional Therapies for Treatment of Peyronie’s Disease

PURPOSE: In this narrative review we explore additional indications for which intralesional collagenase Clostridium histolyticum (CCH) injection therapy may be used, in addition to those utilized in the IMPRESS trials. The goal is to provide updated assessment of available intralesional therapies an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khooblall, Prajit, Bole, Raevti, Lundy, Scott D, Bajic, Petar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290860/ https://www.ncbi.nlm.nih.gov/pubmed/37366388 http://dx.doi.org/10.2147/RRU.S386340

Ejemplares similares

Prostate cancer treatment modality among factors influencing penile prosthesis satisfaction
por: Khooblall, Prajit, et al.
Publicado: (2023)

Rising vasectomy volume following reversal of federal protections for abortion rights in the United States
por: Bole, Raevti, et al.
Publicado: (2023)

Surgical management of National Institutes of Health category II chronic bacterial prostatitis: a case series and scoping review of the literature
por: Orji, Peace U., et al.
Publicado: (2023)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)

Intralesional collagenase may improve pain and curvature in acute phase Peyronie’s patients
por: Fisher, John Samuel, et al.
Publicado: (2022)

Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015)

Staged treatment for substantial bilateral calcium carbonate nephrolithiasis in vegan patient()
por: Khooblall, Prajit, et al.
Publicado: (2021)

Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
por: Cai, Tommaso, et al.
Publicado: (2021)

Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kahn, Barbara, et al.
Publicado: (2017)

Peyronie’s disease: current therapy
por: Pendleton, Clay M., et al.
Publicado: (2013)

Injectable therapy for Peyronie’s disease
por: Chong, Weiliang, et al.
Publicado: (2016)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Prospective study to evaluate the clinical outcome of intralesional interferon-α2b in the management of Peyronie's disease
por: Sokhal, Ashok Kumar, et al.
Publicado: (2018)

Penile traction therapy in Peyronie's disease
por: Greenfield, Jason M
Publicado: (2009)

Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort study
por: Hu, Ming-Yeah Y., et al.
Publicado: (2022)

Cost of Intralesional Collagenase Clostridium Histiolyticum Therapy Versus Surgery for the Management of Peyronie's Disease: A Claims-Based Analysis (2009–2019)
por: Walton, Eric L., et al.
Publicado: (2022)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?
por: Akerman, Jason, et al.
Publicado: (2017)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
por: Zhang, Fuxun, et al.
Publicado: (2022)

Oral therapy for Peyronie’s disease, does it work?
por: Barrett-Harlow, Brittani, et al.
Publicado: (2016)

Peyronie's Disease: Evaluation and Review of Nonsurgical Therapy
por: Abern, Michael R., et al.
Publicado: (2009)

Current and emerging treatment options for Peyronie’s disease
por: Gokce, Ahmet, et al.
Publicado: (2013)

A review of the epidemiology and treatment of Peyronie’s disease
por: Ostrowski, Kevin A, et al.
Publicado: (2016)

Non-invasive treatment in the management of Peyronie’s disease
por: Randhawa, Karen, et al.
Publicado: (2019)

Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study
por: Zucchi, Alessandro, et al.
Publicado: (2016)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Lengthening strategies for Peyronie’s disease
por: Gaffney, Christopher D., et al.
Publicado: (2016)

Penile traction therapy for Peyronie’s disease—what’s the evidence?
por: Usta, Mustafa Faruk, et al.
Publicado: (2016)

Surgical Management for Peyronie's Disease
por: Segal, Robert L., et al.
Publicado: (2013)

US Imaging in Peyronie's Disease
por: Kalokairinou, Kiriaki, et al.
Publicado: (2012)

Psychological aspects of Peyronie’s disease
por: Terrier, Jean E., et al.
Publicado: (2016)

Grafting techniques for Peyronie’s disease
por: Hatzichristodoulou, Georgios
Publicado: (2016)

The Natural History of Peyronie's Disease
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
por: Cocci, Andrea, et al.
Publicado: (2021)

The Non-Surgical Treatment of Peyronie Disease: 2013 Update
por: Shaw, Eric James, et al.
Publicado: (2013)

Peyronie’s disease: contemporary review of non-surgical treatment
por: Levine, Laurence A.
Publicado: (2013)

 Recent advances in managing Peyronie’s disease
por: Kayes, Oliver, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cmneasngfa4toivcj5s6c8roat